FDA.reportPublic FDA data

vadadustat 300 MG Oral Tablet

RxCUI
2679309
RxNorm name
vadadustat 300 MG Oral Tablet
Display name
vadadustat 300 MG Oral Tablet
Full name
vadadustat 300 MG Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:15

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VAFSEOVADADUSTATAkebia Therapeutics, Inc.ac9da724-5a62-4ab6-a89c-376a25f6195b2026-03-30Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2679309

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
ac9da724-5a62-4ab6-a89c-376a25f6195bvadadustat 300 MG Oral Tablet [PSN] · vadadustat 300 MG Oral Tablet [SCD] · vadadustat 300 MG Oral Tablet [SY]34These highlights do not include all the information needed to use VAFSEO safely and effectively. See full prescribing information for VAFSEO. VAFSEO ® (vadadustat) tablets, for oral use Initial U.S. Approval: 202420260330